prospective study for treatment strategies after the decision of allogeneic HSCT in patients with MDS (KSGCT1303/ MDS-prospective)
Not Applicable
- Conditions
- myelodysplastic syndromes (MDS)
- Registration Number
- JPRN-UMIN000013144
- Lead Sponsor
- Kanto Study Group for Cell Therapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with treatment-related MDS. 2.Patients who had received HSCT. 3.Patients who do not provide written informed consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method